Jinming Yang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 1%
- Drug Transport and Resistance Mechanisms
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 9
- Oncology 55
- Drug Transport and Resistance Mechanisms 14
- Cancer-related Molecular Pathways 10
- Co-authors
- William N. Hait (22 shared papers)Ann Richmond (30 shared papers)Xingcong Ren (45 shared papers)Yan Cheng (18 shared papers)Hua Zhu (3 shared papers)Chang‐Gong Liu (4 shared papers)Xisha Chen (9 shared papers)Yan Cheng (13 shared papers)
- Journals
- Cancer Research (15 papers)Genes Chromosomes and Cancer (6 papers)PLoS ONE (5 papers)Cancer Biology & Therapy (5 papers)Biochemical Pharmacology (5 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Jinming Yang
184 papers receiving 7.9k citations
Jinming Yang's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 1.9k
- Oncology 2.2k
- Molecular Biology 4.3k
- Immunology 1.2k
- Physiology 211
Countries citing papers authored by Jinming Yang
This map shows the geographic impact of Jinming Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinming Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinming Yang more than expected).
Fields of papers citing papers by Jinming Yang
This network shows the impact of papers produced by Jinming Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinming Yang. The network helps show where Jinming Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jinming Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 383 | |
| 2 | 2008 | 369 | |
| 3 | DNA Repair Pathways in Cancer Therapy and Resistance Hit paper breakdown → | 2021 | 252 |
| 4 | 2013 | 210 | |
| 5 | 2005 | 180 | |
| 6 | 2017 | 163 | |
| 7 | Constitutive IkappaB kinase activity correlates with nuclear factor-kappaB activation in human melanoma cells. | 2001 | 161 |
| 8 | 2006 | 135 | |
| 9 | 1998 | 130 | |
| 10 | 2011 | 124 | |
| 11 | 2006 | 122 | |
| 12 | 2003 | 122 | |
| 13 | 2013 | 121 | |
| 14 | 2011 | 114 | |
| 15 | 2012 | 110 | |
| 16 | 2018 | 110 | |
| 17 | 2000 | 109 | |
| 18 | 2001 | 108 | |
| 19 | 2003 | 97 | |
| 20 | 2004 | 97 |
About Jinming Yang
Jinming Yang is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Epidemiology, having authored 190 papers that have together received 8.0k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (23 papers), Drug Transport and Resistance Mechanisms (14 papers), Immune Cell Function and Interaction (14 papers), NF-κB Signaling Pathways (14 papers), Immunotherapy and Immune Responses (13 papers), Cancer-related Molecular Pathways (10 papers), Ubiquitin and proteasome pathways (9 papers) and Immune cells in cancer (9 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.2k citations), Molecular Biology (4.3k citations), Immunology (1.2k citations) and Physiology (211 citations). Jinming Yang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include William N. Hait, Ann Richmond, Xingcong Ren, Yan Cheng, Hua Zhu, Chang‐Gong Liu, Xisha Chen, Yan Cheng, Daniel Medina and Yidi Guan. Their work appears in journals such as Cancer Research, Genes Chromosomes and Cancer, PLoS ONE, Cancer Biology & Therapy and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.